Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Long-Term Investments (2016 - 2025)

Macrogenics (MGNX) has disclosed Long-Term Investments for 10 consecutive years, with $132.7 million as the latest value for Q4 2025.

  • Quarterly Long-Term Investments rose 604.82% to $132.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $132.7 million through Dec 2025, up 604.82% year-over-year, with the annual reading at $132.7 million for FY2025, 604.82% up from the prior year.
  • Long-Term Investments for Q4 2025 was $132.7 million at Macrogenics, up from $66.3 million in the prior quarter.
  • The five-year high for Long-Term Investments was $166.5 million in Q3 2023, with the low at $8.6 million in Q1 2025.
  • Average Long-Term Investments over 5 years is $84.7 million, with a median of $106.1 million recorded in 2021.
  • Peak annual rise in Long-Term Investments hit 604.82% in 2025, while the deepest fall reached 91.75% in 2025.
  • Over 5 years, Long-Term Investments stood at $120.1 million in 2021, then crashed by 62.13% to $45.5 million in 2022, then surged by 183.08% to $128.8 million in 2023, then crashed by 85.38% to $18.8 million in 2024, then skyrocketed by 604.82% to $132.7 million in 2025.
  • According to Business Quant data, Long-Term Investments over the past three periods came in at $132.7 million, $66.3 million, and $45.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.